0.60Open0.60Pre Close0 Volume4 Open Interest45.00Strike Price0.00Turnover595.96%IV428.39%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type0.1776Delta0.0271Gamma14.38Leverage Ratio-0.0964Theta0.0003Rho2.55Eff Leverage0.0042Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet